MEK

CAT # Igama lemveliso Inkcazo
CPDB0157 BI-847325 I-BI-847325 i-BEK / Aurora kinase inhibitor ekhethiweyo kunye ne-IC50 ixabiso le-3, i-25, i-15, i-25, kunye ne-4 nM ye-X. laevis Aurora B, i-Aurora A kunye ne-Aurora C, kunye ne-MEK1 yabantu kunye ne-MEK2, ngokulandelanayo. Inokuthintela ukukhula kunye nokusinda kwayo yomibini imigca yeseli ye-melanoma enganyangekiyo kunyango kunye neyeza, inciphisa ukubonakaliswa kwe-MEK kunye ne-Mcl-1 ngelixa inyusa ukubonakaliswa kweprotein ye-pro-apoptotic Bim. Kwi-70 mg / kg, i-BI-847325 yenza i-apoptosis kunyango-naive kunye neyeza-resistant xenografted melanoma in vivo.

Qhagamshelana nathi

Ukubuza

Iindaba zamva

  • Iindlela eziPhezulu ze-7 kuPhando lwezoPhando kwi-2018

    IiNdlela ezi-7 eziphambili kuPhando lwaMayeza...

    Ukuba phantsi koxinzelelo oluhlala lukhula lokukhuphisana kwimeko yezoqoqosho kunye nethekhinoloji ecela umngeni, iinkampani zamayeza kunye nebhayoloji kufuneka ziqhubeke zenza izinto ezintsha kwiinkqubo zazo zeR&D ukuze zihlale phambili ...

  • I-ARS-1620: I-inhibitor entsha ethembisayo ye-KRAS-mutant cancers

    I-ARS-1620: Isithinteli esitsha esithembisayo se-K...

    Ngokophononongo olupapashwe kwiSeli, abaphandi baye baphuhlisa inhibitor ethile ye-KRASG12C ebizwa ngokuba yi-ARS-1602 ebangele ukuhlehla kwethumba kwiimpuku. "Olu phononongo lubonelela ngobungqina bokuba i-KRAS eguqukayo inokuba...

  • I-AstraZeneca ifumana unyuso lolawulo lwamachiza e-oncology

    I-AstraZeneca ifumana unyuso lolawulo lwe...

    I-AstraZeneca ifumene ukongezwa okuphindwe kabini kwipotfoliyo yayo ye-oncology ngoLwesibini, emva kokuba abalawuli base-US naseYurophu bamkele ukungeniswa kolawulo lwamachiza ayo, inyathelo lokuqala lokuphumelela ukuvunywa kwala mayeza. ...

Incoko ka-WhatsApp kwi-Intanethi!